register

News & Trends - Pharmaceuticals

World Cancer Day: Merck and MSCAN leaders dig deeper into ‘Together, we challenge those in power’

Health Industry Hub | February 5, 2024 |

Pharma News: Cancer remains the leading cause of death in Australia. With a multi-year campaign, the World Cancer Day theme is Close the Care Gap. In 2024, the focus of the theme is ‘Together, we challenge those in power’.

Meagan Walsh, Associated Medical Director of Oncology, Merck Healthcare and Tamara Dawson, CEO of MSCAN joined Health Industry Hub in reflecting on their deeply personal passion as cancer advocates.

The duo dug deeper into whether challenging those in power reflects the collective effort needed to bridge existing gaps in cancer care.

The conversation shifted to the landmark Australian Cancer Plan released in November and how each organisation contributed to its development. The discussion expanded to whether the Plan will attract the necessary policy changes and investment required to improve health inequities, especially among culturally and linguistically diverse (CALD) communities, First Nations people, and those living in remote/rural areas.

Addressing the landscape of cancer research funding, the discussion delved into Cancer Australia’s recent data which showed a three-fold increase in funding but ignored the investment from the pharmaceutical industry. Ms Walsh provided insights into how Merck is contributing to cancer research both locally and globally, emphasising the need for a holistic approach, with industry-funded research playing a crucial role.

Lastly, Ms Dawson shared MSCAN’s advocacy priorities for the year and addressed the potential impact of an early federal election on their plans.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Clinicians shift stance, join calls for PBS subsidy of obesity and weight-loss medicines

Clinicians shift stance, join calls for PBS subsidy of obesity and weight-loss medicines

Health Industry Hub | March 14, 2025 |

Over a third of Australian adults live with obesity, and the National Obesity Strategy estimates the direct and indirect costs […]

More


News & Trends - Pharmaceuticals

Astellas secures new indication for prostate cancer drug

Astellas secures new indication for prostate cancer drug

Health Industry Hub | March 14, 2025 |

Astellas Xtandi (enzalutamide) is now TGA registered for a new indication for patients with non-metastatic hormone-sensitive prostate cancer (nmHSPC) with […]

More


News & Trends - MedTech & Diagnostics

Stakeholder calls intensify as government stalls on genetic discrimination ban

Stakeholder calls intensify as government stalls on genetic discrimination ban

Health Industry Hub | March 14, 2025 |

Calls have intensified for the federal government to honour its commitment to outlaw genetic discrimination in life insurance, as stakeholders […]

More


News & Trends - MedTech & Diagnostics

Pressure mounts to expand home-based therapies in kidney disease: World Kidney Day

Pressure mounts to expand home-based therapies in kidney disease: World Kidney Day

Health Industry Hub | March 13, 2025 |

As Australia marks World Kidney Day, the stark reality is that one in three adults is at risk of chronic […]

More


This content is copyright protected. Please subscribe to gain access.